ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Improved memory devices for synthetic cells – Science Magazine

Science MagazineImproved memory devices for synthetic cellsScience MagazineSynthetic biologists have long sought to make cells more like computers. This is not because they think cells will be more efficient than silicon—current microelectronics make e… Continue reading

2018-04-12 Michael Zand NEWS

A controversial technology could save us from starvation — if we let it – Business Insider

Business InsiderA controversial technology could save us from starvation — if we let itBusiness InsiderThe kale, which had been modified using a powerful gene-editing technology called CRISPR, was not allowed in the country. But Jansson, a Swedish plan… Continue reading

2018-04-12 Michael Zand NEWS

Pfizer launches a gene therapy study for Duchenne MD; Amgen, NEA back real-world drug data software company – Endpoints News

Continue reading

2018-04-12 Michael Zand NEWS

Pfizer launches a gene therapy study for Duchenne MD; Amgen, NEA back real-world drug data software company – Endpoints News


Endpoints News

Pfizer launches a gene therapy study for Duchenne MD; Amgen, NEA back real-world drug data software company
Endpoints News
Pfizer has launched its closely-watched study of a new “mini-dystrophin” gene therapy for Duchenne muscular dystrophy. Duke’s Edward Smith dosed the first boy on March 22. And data are expected in H1 of next year, after investigators get a chance to …
Pfizer launches Duchenne gene therapy study, joining Sarepta and SolidBoston Business Journal

all 3 news articles »

Continue reading

2018-04-12 Michael Zand NEWS

Further Evidence that Immunotherapy Provides a Longterm Survival Benefit for Lung Cancer Patients – Drug Discovery & Development

Drug Discovery & DevelopmentFurther Evidence that Immunotherapy Provides a Longterm Survival Benefit for Lung Cancer PatientsDrug Discovery & DevelopmentFurther evidence that immunotherapy provides long-term survival benefit for patients with lung canc… Continue reading

2018-04-12 Michael Zand NEWS

The Market and Potential for CRISPR/Cas9 Gene Editing 2017-2023 – PR Newswire (press release)

Interesting EngineeringThe Market and Potential for CRISPR/Cas9 Gene Editing 2017-2023PR Newswire (press release)In 2018, more than 30 players participate in this market, from large multinational corporations to small, niche life sciences companies. Ke… Continue reading

2018-04-12 Michael Zand NEWS

The Market and Potential for CRISPR/Cas9 Gene Editing 2017-2023 – PR Newswire (press release)

Interesting EngineeringThe Market and Potential for CRISPR/Cas9 Gene Editing 2017-2023PR Newswire (press release)In 2018, more than 30 players participate in this market, from large multinational corporations to small, niche life sciences companies. Ke… Continue reading

2018-04-12 Michael Zand NEWS

Researchers optimize lung stem cell engineering process – Phys.Org

Researchers optimize lung stem cell engineering processPhys.OrgThe Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Center has engineered two new categories of lung epithelial cells in vitro using pluripotent stem cells. … Continue reading

2018-04-12 Michael Zand NEWS
  • 1
  • …
  • 260
  • 261
  • 262
  • 263
  • 264
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Endpoints News

Pfizer launches a gene therapy study for Duchenne MD; Amgen, NEA back real-world drug data software company
Endpoints News
Pfizer has launched its closely-watched study of a new “mini-dystrophin” gene therapy for Duchenne muscular dystrophy. Duke’s Edward Smith dosed the first boy on March 22. And data are expected in H1 of next year, after investigators get a chance to …
Pfizer launches Duchenne gene therapy study, joining Sarepta and SolidBoston Business Journal

all 3 news articles »